keyword
https://read.qxmd.com/read/38611120/scrnaseq-and-high-throughput-spatial-analysis-of-tumor-and-normal-microenvironment-in-solid-tumors-reveal-a-possible-origin-of-circulating-tumor-hybrid-cells
#1
JOURNAL ARTICLE
Abdullah Mahmood Ali, Azra Raza
Metastatic cancer is a leading cause of death in cancer patients worldwide. While circulating hybrid cells (CHCs) are implicated in metastatic spread, studies documenting their tissue origin remain sparse, with limited candidate approaches using one-two markers. Utilizing high-throughput single-cell and spatial transcriptomics, we identified tumor hybrid cells (THCs) co-expressing epithelial and macrophage markers and expressing a distinct transcriptome. Rarely, normal tissue showed these cells (NHCs), but their transcriptome was easily distinguishable from THCs...
April 8, 2024: Cancers
https://read.qxmd.com/read/37954886/evaluating-glycemic-control-efficacy-and-safety-of-the-oral-small-molecule-glucagon-like-peptide-1-receptor-agonist-danuglipron-in-type-2-diabetes-patients-a-systemic-review-and-meta-analysis
#2
REVIEW
Hareer Fatima, Hussain Sohail Rangwala, Muhammad Saqlain Mustafa, Muhammad Ashir Shafique, Syed Raza Abbas, Azra Rizwan, Tagwa Kalool Fadlalla Ahmed, Ainan Arshad
INTRODUCTION: Diabetes Mellitus (DM) is a significant global health concern, with Type 2 DM (T2DM) being highly prevalent. Glucagon-Like Peptide 1 receptor agonists (GLP-1RA), such as Danuglipron, offer potential benefits in T2DM management. This meta-analysis examines the safety and efficacy of Danuglipron, focusing on adverse outcomes and glycemic parameters. METHODS: A systematic search was conducted in PubMed, Scopus, and Cochrane Library for RCTs involving Danuglipron till August 2023, following PRISMA guidelines...
2023: Diabetes, Metabolic Syndrome and Obesity
https://read.qxmd.com/read/37916386/-asxl1-mutations-are-associated-with-a-response-to-alvocidib-and-5-azacytidine-combination-in-myelodysplastic-neoplasms
#3
JOURNAL ARTICLE
Vladimir Riabov, Qingyu Xu, Nanni Schmitt, Alexander Streuer, Guo Ge, Lyndsey Bolanos, Mark Wunderlich, Johann-Christoph Jann, Alina Wein, Eva Altrock, Marie Demmerle, Sanjay Mukherjee, Abdullah Mahmood Ali, Felicitas Rapp, Verena Nowak, Nadine Weimer, Julia Obländer, Iris Palme, Melda Göl, Ahmed Jawhar, Ali Darwich, Patrick Wuchter, Christel Weiss, Azra Raza, Jason M Foulks, Daniel T Starczynowski, Feng-Chun Yang, Georgia Metzgeroth, Laurenz Steiner, Mohamad Jawhar, Wolf-Karsten Hofmann, Daniel Nowak
Inhibitors of anti-apoptotic BCL-2 family proteins in combination with chemotherapy and hypomethylating agents (HMAs) are promising therapeutic approaches in acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS). Alvocidib, a cyclin-dependent kinase 9 (CDK9) inhibitor and indirect transcriptional repressor of the anti-apoptotic factor MCL-1, has previously shown clinical activity in AML. Availability of biomarkers for response to the alvocidib + 5- AZA could also extend the rationale of this treatment concept to high-risk MDS...
November 2, 2023: Haematologica
https://read.qxmd.com/read/37392539/a-rapid-colorimetric-method-for-the-detection-of-carminic-acid-in-samples-based-on-visible-color-change
#4
JOURNAL ARTICLE
Azra Akbar, Amna Jabbar Siddiqui, Syed Tarique Moin, Muhammad Noman Khan, Ali Raza, Adeeba Khadim, Muhammad Usman, M Iqbal Choudhary, Syed Ghulam Musharraf
Carminic Acid (CA), an insect-derived red color, is widely used as a colorant and additive in food and non-food items. The detection of CA is of great concern since it is unacceptable for vegetarians and vegans consumers. Therefore, it is important for food authorities to have a rapid detection method for CA. We describe here a simple and rapid method for the qualitative detection of CA, using Pb2+ for complex formation. As a result, the sample solution shows a visible change from pink to purple (bathochromic shift) which could also be analyzed through a spectrophotometer at λmax  = 605 nm...
June 6, 2023: Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
https://read.qxmd.com/read/37316755/circulating-cancer-giant-cells-with-unique-characteristics-frequently-found-in-patients-with-myelodysplastic-syndromes-mds
#5
JOURNAL ARTICLE
Abdullah Mahmood Ali, Fatima BenMohamed, Alessandra Decina, Sanjay Mukherjee, Shelley Levi, Laura Nalleli Garrido Castillo, Davide Bréchot, Joseph Jurcic, Azra Raza, Patrizia Paterlini Bréchot
Myelodysplastic syndromes (MDS) are incurable diseases characterized by dysplastic hematopoietic cells, cytopenias in the blood and an inherent tendency for transformation to secondary acute myeloid leukemia (AML). Since most therapies fail to prevent rapid clonal evolution and disease resistance, new and non-invasive predictive markers are needed to monitor patients and adapt the therapeutic strategy. By using ISET, a very sensitive approach to isolate cells larger than mature leukocytes from peripheral blood samples, we looked for cellular markers in 99 patients (158 samples) with MDS and 66 healthy individuals (76 samples) used as controls...
June 14, 2023: Medical Oncology
https://read.qxmd.com/read/37262051/tracking-sars-cov-2-variants-through-pandemic-waves-using-rt-pcr-testing-in-low-resource-settings
#6
JOURNAL ARTICLE
Asghar Nasir, Uzma Bashir Aamir, Akbar Kanji, Ali Raza Bukhari, Zeeshan Ansar, Najia Karim Ghanchi, Kiran Iqbal Masood, Azra Samreen, Nazneen Islam, Samina Ghani, M Asif Syed, Mansoor Wassan, Syed Faisal Mahmood, Zahra Hasan
COVID-19 resulted in extensive morbidity and mortality worldwide. SARS-CoV-2 evolved rapidly, with increasing transmission due to Variants of Concern (VOC). Identifying VOC became important but genome submissions from low-middle income countries (LMIC) remained low leading to gaps in genomic epidemiology. We demonstrate the use of a specific mutation RT-PCR based approach to identify VOC in SARS-CoV-2 positive samples through the pandemic in Pakistan. We selected 2150 SARS-CoV-2 PCR positive respiratory specimens tested between April 2021 and February 2022, at the Aga Khan University Hospital Clinical Laboratories, Karachi, Pakistan...
2023: PLOS Glob Public Health
https://read.qxmd.com/read/36965642/untargeted-metabolomics-analysis-of-gentamicin-induced-tolerant-colonies-of-klebsiella-pneumoniae
#7
JOURNAL ARTICLE
Ali Raza, Moatter Zehra, Muhammad Ramzan, Amna Jabbar Siddiqui, Azra Akbar, Ayaz Ahmed, Syed Ghulam Musharraf
PURPOSE: Antibiotic resistance development in pathogenic bacteria like Klebsiella pneumoniae seriously threatens humankind. Therefore, it is important to understand the interaction of bacteria with antibiotic agents and how it acquires resistance at the molecular level. The current study describes metabolomics analysis of K. pneumoniae sensitive strains and its gentamicin-tolerant (resistant) strains. METHODS: K. pneumoniae strains were treated at five different concentrations of gentamicin, increasing from a low dose (16...
March 23, 2023: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/36849377/rising-resistance-in-uropathogens-with-an-indication-of-nitrofurantoin-mic-creep
#8
JOURNAL ARTICLE
Azra S Hasan, Richa Garg, Sowmya Nasimuddin, Sneha Dey, Ayan Das, Syed Md Moosi Raza Ali, Sumit Rai, Dalip K Kakru
BACKGROUND: The irrational use of antibiotics has led to the emergence of multi drug resistant pathogens. The phenomenon of MIC creeps occurs when organisms start showing raised MIC but within susceptible range giving an indication of the prevalence of rise in resistant pathogens in an area. METHODS: A cross sectional study in a large tertiary care hospital in North India to observe the susceptibility pattern among uropathogens and the possibility of MIC creeps...
2023: Journal of Ayub Medical College, Abbottabad: JAMC
https://read.qxmd.com/read/35478057/mutation-in-sf3b1-gene-promotes-formation-of-polyploid-giant-cells-in-leukemia-cells
#9
JOURNAL ARTICLE
Sanjay Mukherjee, Abdullah Mahmood Ali, Vundavalli V Murty, Azra Raza
Giant cells with polyploidy, termed polyploid giant cells, have been observed during normal growth, development, and pathologic states, such as solid cancer progression and resistance to therapy. Functional studies of polyploidal giant cancer cells (PGCC) provided evidence that they arise when normal diploid cells are stressed, show stem cell-like properties, and give rise to tumors. In the present study, we report in K562 leukemia cell line that introduction of the hotspot K700E mutation in the gene SF3B1 using CRISPR/Cas9 method results in an increased frequency of multinucleated polyploid giant cells resistant to chemotherapeutic agent and serum starvation stress...
April 28, 2022: Medical Oncology
https://read.qxmd.com/read/35046097/subversion-of-serotonin-receptor-signaling-in-osteoblasts-by-kynurenine-drives-acute-myeloid-leukemia
#10
JOURNAL ARTICLE
Marta Galán-Díez, Florence Borot, Abdullah Mahmood Ali, Junfei Zhao, Eva Gil-Iturbe, Xiaochuan Shan, Na Luo, Yongfeng Liu, Xi-Ping Huang, Brygida Bisikirska, Rossella Labella, Irwin Kurland, Bryan L Roth, Matthias Quick, Siddhartha Mukherjee, Raul Rabadán, Martin Carroll, Azra Raza, Stavroula Kousteni
Remodeling of the microenvironment by tumor cells can activate pathways that favor cancer growth. Molecular delineation and targeting of such malignant-cell nonautonomous pathways may help overcome resistance to targeted therapies. Herein we leverage genetic mouse models, patient-derived xenografts, and patient samples to show that acute myeloid leukemia (AML) exploits peripheral serotonin signaling to remodel the endosteal niche to its advantage. AML progression requires the presence of serotonin receptor 1B (HTR1B) in osteoblasts and is driven by AML-secreted kynurenine, which acts as an oncometabolite and HTR1B ligand...
April 1, 2022: Cancer Discovery
https://read.qxmd.com/read/34930825/sf3b1-mutant-induced-missplicing-of-map3k7-causes-anemia-in-myelodysplastic-syndromes
#11
JOURNAL ARTICLE
Yen K Lieu, Zhaoqi Liu, Abdullah M Ali, Xin Wei, Alex Penson, Jian Zhang, Xiuli An, Raul Rabadan, Azra Raza, James L Manley, Siddhartha Mukherjee
SF3B1 is the most frequently mutated RNA splicing factor in cancer, including in ∼25% of myelodysplastic syndromes (MDS) patients. SF3B1-mutated MDS, which is strongly associated with ringed sideroblast morphology, is characterized by ineffective erythropoiesis, leading to severe, often fatal anemia. However, functional evidence linking SF3B1 mutations to the anemia described in MDS patients harboring this genetic aberration is weak, and the underlying mechanism is completely unknown. Using isogenic SF3B1 WT and mutant cell lines, normal human CD34 cells, and MDS patient cells, we define a previously unrecognized role of the kinase MAP3K7, encoded by a known mutant SF3B1-targeted transcript, in controlling proper terminal erythroid differentiation, and show how MAP3K7 missplicing leads to the anemia characteristic of SF3B1-mutated MDS, although not to ringed sideroblast formation...
January 4, 2022: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/34021930/comprehensive-phenotyping-of-erythropoiesis-in-human-bone-marrow-evaluation-of-normal-and-ineffective-erythropoiesis
#12
JOURNAL ARTICLE
Hongxia Yan, Abdullah Ali, Lionel Blanc, Anupama Narla, Joseph M Lane, Erjing Gao, Julien Papoin, John Hale, Christopher D Hillyer, Naomi Taylor, Patrick G Gallagher, Azra Raza, Sandrina Kinet, Narla Mohandas
Identification of stage-specific erythroid cells is critical for studies of normal and disordered human erythropoiesis. While immunophenotypic strategies have previously been developed to identify cells at each stage of terminal erythroid differentiation, erythroid progenitors are currently defined very broadly. Refined strategies to identify and characterize BFU-E and CFU-E subsets are critically needed. To address this unmet need, a flow cytometry-based technique was developed that combines the established surface markers CD34 and CD36 with CD117, CD71, and CD105...
September 1, 2021: American Journal of Hematology
https://read.qxmd.com/read/33395237/novel-multicancer-early-detection-technology-potential-value-to-employers-and-the-workforce
#13
JOURNAL ARTICLE
Joshua J Ofman, A Mark Fendrick, Azra Raza
Multicancer early detection technology could help reduce cancer mortality compared to the current strategy of single-cancer screening tests.
December 2020: American Journal of Managed Care
https://read.qxmd.com/read/33108243/imetelstat-achieves-meaningful-and-durable-transfusion-independence-in-high-transfusion-burden-patients-with-lower-risk-myelodysplastic-syndromes-in-a-phase-ii-study
#14
MULTICENTER STUDY
David P Steensma, Pierre Fenaux, Koen Van Eygen, Azra Raza, Valeria Santini, Ulrich Germing, Patricia Font, Maria Diez-Campelo, Sylvain Thepot, Edo Vellenga, Mrinal M Patnaik, Jun Ho Jang, Helen Varsos, Jacqueline Bussolari, Esther Rose, Laurie Sherman, Libo Sun, Ying Wan, Souria Dougherty, Fei Huang, Faye Feller, Aleksandra Rizo, Uwe Platzbecker
PURPOSE: Patients with lower-risk (LR) myelodysplastic syndromes (MDS) who are RBC transfusion dependent and have experienced relapse after or are refractory to erythropoiesis-stimulating agent (ESA) have limited treatment options. High telomerase activity and human telomerase reverse-transcription expression in clonal hematopoietic cells have been reported in patients with MDS. Imetelstat, a first-in-class competitive inhibitor of telomerase enzymatic activity, targets cells with active telomerase...
January 1, 2021: Journal of Clinical Oncology
https://read.qxmd.com/read/32318330/rewriting-the-rules-for-care-of-mds-and-aml-patients-in-the-time-of-covid-19
#15
JOURNAL ARTICLE
Azra Raza, Amer Assal, Abdullah M Ali, Joseph G Jurcic
The care of patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) has been radically altered by COVID-19, especially in New York City, the epicenter of the pandemic. Here we summarize how telemedicine, virtual visits, delayed transfusions, and chemotherapy, preferably selecting self-administered medications and visits by home healthcare workers, are employed to minimize exposure of our high-risk population of patients to the virus. The unique challenges of transplants during the pandemic and the consequences of an abrupt halt in all non-essential research activities are described...
2020: Leukemia Research Reports
https://read.qxmd.com/read/31481052/in-vivo-assessment-of-anticoagulant-and-antiplatelet-effects-of-syzygium-cumini-leaves-extract-in-rabbits
#16
JOURNAL ARTICLE
Ahad Abdul Rehman, Azra Riaz, Muhammad Arif Asghar, Muhammad Liaquat Raza, Shadab Ahmed, Kamran Khan
BACKGROUND: Syzygium cumini (L.) Skeels. is one of the very popular traditionally used medicinal plants with numerous pharmacological activities including antioxidant, hypoglycemic and anti-inflammatory. However, actions of S. cumini on blood coagulation and other parameters of blood were poorly pharmacologically studied. Therefore, aim of this present investigation is to examine the effects of methanolic extract of S. cumini on blood coagulation and anticoagulation factors in healthy white albino rabbits at different doses...
September 3, 2019: BMC Complementary and Alternative Medicine
https://read.qxmd.com/read/31474574/disease-causing-mutations-in-sf3b1-alter-splicing-by-disrupting-interaction-with-sugp1
#17
JOURNAL ARTICLE
Jian Zhang, Abdullah M Ali, Yen K Lieu, Zhaoqi Liu, Jianchao Gao, Raul Rabadan, Azra Raza, Siddhartha Mukherjee, James L Manley
SF3B1, which encodes an essential spliceosomal protein, is frequently mutated in myelodysplastic syndromes (MDS) and many cancers. However, the defect of mutant SF3B1 is unknown. Here, we analyzed RNA sequencing data from MDS patients and confirmed that SF3B1 mutants use aberrant 3' splice sites. To elucidate the underlying mechanism, we purified complexes containing either wild-type or the hotspot K700E mutant SF3B1 and found that levels of a poorly studied spliceosomal protein, SUGP1, were reduced in mutant spliceosomes...
October 3, 2019: Molecular Cell
https://read.qxmd.com/read/31138698/gene-edited-stem-cells-enable-cd33-directed-immune-therapy-for-myeloid-malignancies
#18
JOURNAL ARTICLE
Florence Borot, Hui Wang, Yan Ma, Toghrul Jafarov, Azra Raza, Abdullah Mahmood Ali, Siddhartha Mukherjee
Antigen-directed immunotherapies for acute myeloid leukemia (AML), such as chimeric antigen receptor T cells (CAR-Ts) or antibody-drug conjugates (ADCs), are associated with severe toxicities due to the lack of unique targetable antigens that can distinguish leukemic cells from normal myeloid cells or myeloid progenitors. Here, we present an approach to treat AML by targeting the lineage-specific myeloid antigen CD33. Our approach combines CD33-targeted CAR-T cells, or the ADC Gemtuzumab Ozogamicin with the transplantation of hematopoietic stem cells that have been engineered to ablate CD33 expression using genomic engineering methods...
May 28, 2019: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/30362079/improving-treatment-for-myelodysplastic-syndromes-patients
#19
REVIEW
Julia Montoro, Aslihan Yerlikaya, Abdullah Ali, Azra Raza
Aging is the most potent of carcinogens, especially for the bone marrow stem cell clonal disorders called myelodysplastic syndromes (MDS). Age-associated changes in the microenvironment or the soil of the bone marrow (BM) as well as in the cell or the seed provide a growth advantage for clonal myeloid cells. Slowly accumulating senescent cells which can no longer divide because they have reached the end of their proliferative life cycle, but which continue to produce metabolic debris, overwhelm the natural autophagy mechanisms resulting in pro-inflammatory changes in the BM soil...
October 25, 2018: Current Treatment Options in Oncology
https://read.qxmd.com/read/29903708/severely-impaired-terminal-erythroid-differentiation-as-an-independent-prognostic-marker-in-myelodysplastic-syndromes
#20
JOURNAL ARTICLE
Abdullah Mahmood Ali, Yumin Huang, Ronald Feitosa Pinheiro, Fumin Xue, Jingping Hu, Nicholas Iverson, Daniela Hoehn, Diego Coutinho, Jehanzeb Kayani, Brian Chernak, Joseph Lane, Christopher Hillyer, Naomi Galili, Joseph Jurcic, Narla Mohandas, Xiuli An, Azra Raza
Anemia is the defining feature in most patients with myelodysplastic syndromes (MDS), yet defects in erythropoiesis have not been well characterized. We examined freshly obtained bone marrow (BM) samples for stage-specific abnormalities during terminal erythroid differentiation (TED) from 221 samples (MDS, n = 205 from 113 unique patients; normal, n = 16) by measuring the surface expression of glycophorin A, band 3, and integrin α-4. Clinical and biologic associations were sought with presence or absence of TED and the specific stage of erythroid arrest...
June 26, 2018: Blood Advances
keyword
keyword
85916
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.